Search clinical trials for: Zalviso

Total 13 results

Centre Hospitalier Universitaire, Amiens
Pitié-Salpêtrière Hospital

Completed

Medico-economic Evaluation of Sublingual PCA (Zalviso) Versus Oxycodone-PCA in the Management of Postoperative Pain. (MEZO)

Analgesia

France
University Hospital, Ghent

Completed

Safety and Efficacy of Patient Controlled Analgesia Using the Sublingual Sufentanil Tablet System (SSTS) in a Fast Track Rehabilitation Program After Total Knee Arthroplasty (Zalviso)

Postoperative Pain

Belgium
Hospices Civils de Lyon

Completed

Sublingual Sufentanil PCA Usability for Postoperative Pain (Zalviso® System) (USE-SSPC)

Trauma | Surgery

France
Hospital Central do Funchal

Completed

Morphine vs Sufentanil PCA: Same Same or Different?

Chronic Pain | Analgesia | Patient Satisfaction | Post Operative Pain

Portugal
Centre Hospitalier Universitaire de Tivoli

Completed

Sufentanil Sublingual Tablet System for Postoperative Pain Management After Total Knee Arthroplasty

Postoperative Pain

Belgium
University Hospital, Antwerp
Universiteit Antwerpen

Completed

Sublingual Sufentanil Tablet System (SSTS) Versus Intravenous Patient Controlled Analgesia After Back Surgery.

Pain, Postoperative

Belgium
IRCCS San Raffaele

Unknown

Acute Post-operative Pain in Colon Resections (ERAS-PO)

Analgesia

Italy
AcelRx Pharmaceuticals, Inc.

Completed

Study to Evaluate the Overall Performance of the Zalviso System™ (Sufentanil Sublingual Tablet System) 15 mcg

Moderate-to-severe Acute Pain

United States
University Hospital Tuebingen

Unknown

Observational Study of Analgesia and Cost-efficiency of Analgetic Medication Pumps (Zalviso and PCA-syringe Pump (PCA=Patient Controlled Analgesia)) After Urogenital Intervention at the Clinical Daily Routine

Mobility | Analgesic Quality

Germany
AcelRx Pharmaceuticals, Inc.

Completed

Efficacy and Safety Trial to Evaluate the Sufentanil NanoTab® PCA System/15 mcg (Zalviso™) for Post-Operative Pain in Patients After Knee or Hip Replacement Surgery

Post Operative Pain

United States
AcelRx Pharmaceuticals, Inc.

Completed

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™) for the Treatment of Post-Operative Pain in Patients After Open Abdominal Surgery

Post-Operative Pain

United States
AcelRx Pharmaceuticals, Inc.

Completed

A Multicenter, Randomized, Open-Label, Parallel-Group Trial to Compare the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™)to Intravenous Patient-Controlled Analgesia With Morphine for the Treatment of Acute Post-Operative Pain

Post-Operative Pain

United States
AcelRx Pharmaceuticals, Inc.

Completed

Single and Multiple Dose Pharmacokinetics of Sufentanil NanoTab

Plasma Concentrations

United States

3

Subscribe